Menu

Comparative effects of glycine and d-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis

By Heresco-Levy U., Javitt D.C. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite

Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study

By Louza M.R., Marques A.P., Elkis H., Bassitt D., Diegoli M., Gattaz W.F. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite

Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia

By Harvey P.D., Meltzer H., Simpson G.M., Potkin S.G., Loebel A., Siu C., Romano S.J. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite

Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample

By Kavanagh D.J., Waghorn G., Jenner L., Chant D.C., Carr V., Evans M., Herrman H., Jablensky A., McGrath J.J. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

By HGDH Research Group, Green A.I., Tohen M.F., Hamer R.M., Strakowski S.M., Lieberman J.A., Glick I., Scott Clark W. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite

Changes in caudate volume after exposure to atypical neuroleptics in patients with schizophrenia may be sex-dependent

By Heitmiller D.R., Nopoulos P.C., Andreasen N.C. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite

Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia

By Buckley P.F., Goldstein J.M., Emsley R.A. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite

Differential effects of long-term treatment with clozapine or haloperidol on GABA A receptor binding and GAD 67 expression

By Zink M., Schmitt A., May B., Muller B., Demirakca T., Braus D.F., Henn F.A. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite

Clozapine's effects on body weight and resting metabolic rate: a case series

By Procyshyn R.M., Chau A., Tse G. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite

Smokers and nonsmokers equally affected by olanzapine-induced weight gain: metabolic implications

By Lasser R.A., Mao L., Gharabawi G. in (2004)

Elsevier

Abstract Access to resources Recommend Favorite